AdvanSix is a manufacturer of Nylon 6, a polymer resin which is a synthetic material used by the company's customers to produce plastics, fibers, filaments and films that, in turn, are used in such end-products as automotive and electronic components, carpets, sports apparel, fishing nets and food and industrial packaging. The company also sells other products including caprolactam, ammonium sulfate fertilizers, and other chemical intermediates. The company sells its Nylon 6 resin under the Aegis? brand name, its nylon films under the Capran? brand name and its ammonium sulfate fertilizer under the Sulf-N? brand name. Chemical intermediates are also sold under the brand names of Nadone?, Naxol? and EZ-Blox?.

Apollo Medical Holdings is a physician-centric integrated population health management company providing coordinated, outcomes-based medical care and serving patients in California, the majority of whom are covered by private or public insurance provided through Medicare, Medicaid and health maintenance organizations. The company provides care coordination services to each main constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups and health plans. The company's physician network consists of primary care physicians, specialist physicians and hospitalists.

Capital City Bank Group is a financial holding company. Through its subsidiary, Capital City Bank (the Bank), the company provides deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services. The company has three principal services: Banking Services, which is engaged in the commercial and retail banking business; Trust and Asset Management Services, which provides asset management for individuals through agency, personal trust, IRA, and personal investment management accounts; and Brokerage Services, which provides its customers access to retail investment products through LPL Financial.

Carriage Services is a provider of funeral and cemetery services and merchandise. The company operates in two business segments: funeral home operations, which provide a range of services, including consultation, the removal and preparation of remains, the sale of caskets and related funeral merchandise, the use of funeral home facilities for visitation and services and transportation services; and cemetery operations, which include a range of products and services including interment services, the rights to interment in cemetery sites (primarily grave sites, mausoleum crypts and niches) and related cemetery merchandise, such as memorials and vaults.

ClearOne designs, develops and sells conferencing, collaboration and network streaming solutions for voice and visual communications. The company's line of conferencing and collaboration products are targeted for large, medium and small businesses, as well as for personal use. The company's products can be categorized into the following: audio conferencing including installed DSP based professional audio conferencing, USB-based speakerphones and table-top audio conferencing; microphones consisting of patented beamforming microphones, ceiling microphones and wireless microphones; and video products including video collaboration and AV networking.

CubicFarm Systems Corp is a Canada-based agriculture technology and vertical farming company. The Company develops and employs technology to provide predictable crop yields. The Company installs turnkey commercial scale, hydroponic, automated vertical farm growing solutions. It also provides a seed to store shelf solution including design, installation, training, packaging, marketing and branding support. Its system addresses the two challenges in the vertical farming industry, high electricity and labor costs, using undulating path technology. The Company leverages its technology by operating its own facility in Pitt Meadows, British Columbia.

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing muscle activators and muscle inhibitors as treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company's clinical-stage drug candidates are: omecamtiv mecarbil, a cardiac myosin activator for the treatment of heart failure, AMG 594, a cardiac troponin activator, reldesemtiv, a skeletal muscle troponin activator for the treatments of spinal muscular atrophy and amyotrophic lateral sclerosis, and CK-3773274, a cardiac myosin inhibitor which is designed to reduce the hypercontractility that is associated with hypertrophic cardiomyopathy.

Fluent provides digital marketing services. The company primarily performs customer acquisition services by operating digital marketing campaigns, through which the company connects its advertiser clients with consumers. The company delivers data and performance-based marketing executions to its clients, across a range of industries, including Financial Services, Retail and Consumer, Media and Entertainment, Staffing and Recruitment and Marketing Services. The company provides performance marketing solutions to its clients based on their desired outcomes, or specific actions in their marketing funnels, including submission of a registration form, app installation or a completed transaction.

Opko Health is a healthcare company. The company manages two segments: Diagnostics, which provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health and correctional healthcare; and Pharmaceutical, which includes Rayaldee for the treatment of secondary hyperparathyroidism in adults with chronic kidney disease (CKD) and vitamin D insufficiency, and Alpharen (Fermagate Tablets) for the treatment of hyperphosphatemia in CKD patients requiring regular hemodialysis.

Pope Resources is engaged primarily in managing timber resources on its own properties as well as those owned by others. The company operates in four business segments: Partnership Timber, and Funds Timber, which both consist of growing, managing, harvesting, and marketing timber; Timberland Investment Management, which is engaged in organizing and managing private equity timber funds using capital invested by third parties and the company; and Real Estate, which is focused on a portfolio in the west Puget Sound region of Washington, most of which are legacy timberlands that have become suitable as development property owing to the expansion of the Puget Sound metropolitan and suburban areas.

resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapeutics for the treatment of aging-related diseases. The company's initial focus is on the development of RTB101, an orally administered, small molecule, target of rapamycin complex 1 inhibitor, alone and in combination with other mechanistic target of rapamycin inhibitors such as everolimus, as an immunotherapy program designed to improve immune function and thereby reduce the incidence of respiratory tract infections in the elderly regardless of the causative pathogen.

Rocket Pharmaceuticals is a clinical-stage, multi-platform biotechnology company focused on the development of gene therapies for rare and devastating pediatric diseases. The company has the following inical-stage ex vivo lentiviral vector programs enrolling patients in the U.S. and European Union for Fanconi Anemia, a genetic defect in the bone marrow that reduces production of blood cells or promotes the production of faulty blood cells, Leukocyte Adhesion Deficiency-I, a genetic disorder that causes the immune system to malfunction and Pyruvate Kinase Deficiency, a rare red blood cell autosomal recessive disorder that results in chronic non-spherocytic hemolytic anemia.

Zuora is a cloud-based subscription management platform. The company's solution is the system of record for its customers' subscription business models and consists of three components: the company's Zuora Central Platform, which platform acts as an intelligent subscription management hub, allowing customers to orient operations around it to create a process designed for subscription business models; other products, which consists of Zuora Billing and Zuora RevPro; and an application marketplace, which the Zuora Marketplace provides industry-specific tools and third-party applications that extend the company's capabilities for its customers.